Meghalaya allocates 8% of budget to health, highest in country
Shillong: Meghalaya now allocates eight per cent of its total state budget to health — the highest in the country, an official statement said on Monday.
"Since 2010, the state's health budget has grown nearly six-fold, from Rs 300 crore to Rs 1,700 crore in 2023.
Tired of too many ads? go ad free now
Major investments have been made across Primary and Community Health Centres, sub-centres, and district hospitals — covering infrastructure, medical equipment, IT systems, storage, logistics, and real-time monitoring of supplies," the statement highlighted on occasion of the first Meghalaya Health Summit 2025 organised by the state department of health & family welfare, in collaboration with the National Health Mission, at the State Convention Centre here, which was chaired by CM Conrad K Sangma, and attended by senior officials, public health experts, and private healthcare stakeholders.
During the summit, the CM distributed appointment letters to over 200 newly recruited nurses under the Meghalaya Medical Services Recruitment Board (MMSRB) and 115 staff under the National AYUSH Mission (NAM). Congratulating the recruits, the CM said, "This is more than just a job — it's a calling. Approach every patient with empathy; your compassion can transform lives".
The CM also launched the Meghalaya State Antibiotic Policy 2025-2026.
The CM mentioned that in 2018, facing a shortage of doctors, the govt recruited 500 doctors in just three months post-cabinet approval. "Our aim is clear — no resident should need to go outside Meghalaya for treatment. We're working to make our healthcare system a regional and international hub, while also inviting private sector partnerships to strengthen rural services," he said.
Health minister Mazel Ampareen Lyngdoh urged new recruits to serve where they're most needed and called on more youth to pursue nursing.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
2 hours ago
- Time of India
IIT Guwahati develops mechanism to treat 1,000 litre contaminated water for Rs 20
New Delhi: Researchers at Indian Institute of Technology (IIT), Guwahati, have developed a low-cost community scale water treatment system that removes fluoride and iron from groundwater and can treat up to 20,000 litre of contaminated water per day, officials said. The findings of the research have been published in the prestigious ACS ES&T Water journal. The researchers claimed the system was highly affordable and could treat 1,000 litre of water at a paltry Rs 20. According to Mihir Kumar Purkait, Professor at Department of Chemical Engineering, IIT Guwahati , fluoride, a mineral generally used in dental care products, pesticides, fertilisers and some industrial processes, can enter groundwater either naturally or through human activities such as agriculture and manufacturing. "Consumption of water with excess fluoride presence can lead to skeletal-fluorosis, a serious health condition in which bones harden and joints become stiff, making physical movement difficult and painful. In India, states including Rajasthan, Telangana, Andhra Pradesh, Karnataka, Haryana, and Gujarat, among others, face high levels of fluoride in groundwater," Purkait said. The IIT Guwahati research team developed a four-step system that ensures a cost-effective and energy-efficient technology for contaminated water treatment. Purkait said the hydrogen and oxygen bubbles produced during electrolysis interact with air bubbles, assisting in lifting pollutant particles to the surface. The selection of electrode material depends on factors like low cost, low oxidation potential and high electro-positivity after dissolution. "Among available options, aluminum has proven highly effective, particularly in the removal of iron, arsenic, and fluoride under optimal operational conditions," he said. The research team tested the developed system under real-world conditions for 12 weeks and recorded consistent performance. The results have shown removal of 94 per cent iron and 89 per cent fluoride from the wastewater, bringing the levels within safe limits set by Indian standards. "A key feature of the developed system is its cost effectiveness, with Rs 20 per 1,000 liters of treated water, making it highly affordable. The developed technology requires minimal supervision and has a projected lifespan of 15 years with electrode replacement scheduled every six months," he said. The study proposes a method to estimate electrode life using a built-in safety factor to ensure timely maintenance. As a pilot project, in support with the Public Health Engineering Department of Assam, the developed technology has been successfully installed by Kakati Engineering Pvt Ltd in Changsari, Assam. "We are also exploring the use of solar or wind power to operate the unit and to utilise the hydrogen gas generated during electrocoagulation process . By integrating smart technologies such as real-time sensors and automated controls, we will be able to further reduce the need for manual intervention, making the system more effective for remote and underserved areas," he said. The research team also aims to combine the current system with other water treatment methods to enhance performance and provide a decentralised water treatment solution. PTI
Time of India
2 hours ago
- Time of India
Inquiry committee submits report on VS illegal trials to Ahmedabad municipal commissioner
Ahmedabad: A five-member AMC committee completed its investigation into the alleged illegal clinical trials at VS Hospital and submitted a report, implicating top doctors in a multi-crore scam. Between 2021 and 2025, 58 unauthorized trials were conducted on over 500 patients in complete violation of rules, with payments from pharmaceutical companies routed to the accounts of senior doctors, instead of the hospital, said sources citing the report. The panel, led by the head of the AMC vigilance department, has reportedly recommended disciplinary action against all responsible parties. The municipal commissioner is now reviewing the report to decide whether a police complaint should be filed. Sources citing the inquiry report, which includes a 30-page summary and 500 pages of annexures, said that the key accused include then superintendent Dr Manish Patel, clinical head Dr Devang Rana, and contract doctor Dhaivat Shukla. "The trio allegedly siphoned off between Rs 17 crore to Rs 20 crore from pharmaceutical companies into their personal and family accounts. In some cases, money was also deposited into the accounts of unrelated individuals," revealed a source close to the development. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Memperdagangkan CFD Emas dengan salah satu spread terendah? IC Markets Mendaftar Undo The scam came to light after Rajshree Kesari, a Congress councillor from Chandkheda, filed a complaint, alleging that doctors were conducting illegal trials and depositing the money into private bank accounts. After conducting a preliminary investigation, the municipal commissioner then formed a special five-member inquiry panel on April 19. However, after questions were raised about one panel member's credibility, AMC's in-charge health officer Dr Bhavin Solanki was included in the committee. The probe was overseen by Hina Bhathawala, AMC's vigilance department chief. Earlier, eight doctors, including Dr Rana, were suspended, and a notice was served to the retired hospital superintendent. The committee also recorded statements from Dr Patel, Dr Rana, and other implicated personnel. A source, citing the inquiry report, said, "Over four years, 58 pharmaceutical companies conducted various unregulated vaccine and drug clinical research on more than 500 patients. The companies legally paid Rs 17 to 20 crore, none of which reached the hospital's official accounts. Instead, they were deposited into accounts belonging to Dr Patel, Dr Rana, Dr Shukla, their spouses, and even family HUF accounts. Some payments were allegedly made in cash. "The clinical trials were allegedly conducted using the approval of a private ethical committee instead of seeking clearance from the AMC, the hospital's management board, or the Medical Education Trust." Documents pertaining to these trials were either poorly maintained or deliberately concealed, said sources, drawing from the report. Despite a claim from Dr Patel that Rs 6 crore was deposited into the hospital account, the committee found no supporting documentation.
Time of India
2 hours ago
- Time of India
Delhi consumer commission holds lab liable for faulty test report that led to hospitalisation
New Delhi: A faulty lab test report that triggers panic and emergency hospitalisation amounts to a deficiency in service, Delhi State Consumer Disputes Redressal Commission (DSCDRC) has said, asking a private pathology laboratory to compensate the affected customer. In a recent ruling, the state commission upheld the findings of a district consumer forum against Dr Lal Pathlabs and observed that its "grossly erroneous results constitute a failure to perform basic testing accurately, causing undue distress and unnecessary hospitalisation." Dismissing the appeal filed by the lab, the bench of Justice Sangita Dhingra Sehgal (president) and Pinki (member judicial) noted that if "the tests carried out by a laboratory are defective and erroneous, then the diagnosis by the doctor will not be correct, and the patient will not get the proper treatment. The medicines prescribed based on a wrong test report and diagnosis may lead to fatal results for the patient. When a patient's urea levels are reported at more than ten times the normal range, triggering emergency hospitalisation and profound distress, the laboratory cannot retreat behind semantic arguments about its limited role in the diagnostic chain." According to the complainant, on receiving the test report showing abnormally high creatinine levels at 8.39 mg/dl and urea at 189 mg/dl, while the reference range of creatinine is 0.6-1.3 mg/dl and urea at 6-21 mg/dl, the treating doctor directed immediate hospitalisation and further tests while preparing for a procedure. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 임플란트 29만원 이벤트 임플란트 더 알아보기 Undo However, further tests within 24-48 hours revealed normal readings. The same tests were conducted at two other private labs, which also showed the patient's parameters to be within the normal range. "It is to be noted that the medical expenses incurred by the respondent were directly attributable to the appellant's erroneous report, which falsely indicated life-threatening conditions and necessitated emergency hospitalisation ," the commission said. Rejecting the challenge to the award of Rs 3.5 lakh as compensation payable by the laboratory, the state commission pointed out that being "misdiagnosed with life-threatening conditions and undergoing unnecessary hospitalisation constitutes severe psychological trauma. The mental agony and physical suffering cannot be understated. Also, the prolonged litigation justifies litigation costs as a component of compensation. " Dr Lal Pathlabs said that there was no deficiency in service and that the tests were conducted under strict quality control protocols.
